Eric Lévesque MD, Ph.D

Associate Professor, Laval University, Faculty of Medicine
CIHR Clinician-Scientist

MD Internal medicine, Hematology/Oncology
Bachelor in biochemistry, M.Sc. and Ph.D. degree in Molecular Oncology

Joined in for a post-doc: 2006-2010; Now an independant investigator

Research project :
– Pharmacogenomics and Drug treatment

Nickname : Loulou
Likes : The boss !!!
Dislikes : searching his keys … every day.

Email: eric.levesque.1@ulaval.ca

List of publications

Manuscripts

Lévesque E, Ménard V, Laverdière I, Bellemare J, Barbier O, Girard H, Guillemette C.
Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation.
Pharmacogenet Genomics. 2010 Mar;20(3):195-210.

Guillemette C, Lévesque E, Harvey M, Bellemare J, Menard V.
UGT genomic diversity: beyond gene duplication.
Drug Metab Rev. 2010;42(1):22-42.

Guillemette C, Lévesque E, Harvey M, Bellemare J, Menard V.
UGT genomic diversity: beyond gene duplication.
Drug Metab Rev. 2009 Sep 30. [Epub ahead of print]

Ménard V, Eap O, Harvey M, Guillemette C, Lévesque E.
Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.
Hum Mutat. 2009 Sep;30(9):1310-9.

Levesque E, Bradette M.
Hepatotoxicity as a rare but serious side effect of Thalidomide.
Ann Hematol. 2008 Jul 30. [Epub ahead of print]

Eric Lévesque, Marie-Odile Benoit-Biancamano, Robert Delage, Félix Couture and Chantal Guillemette.
Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers: A comprehensive analysis of polymorphisms at the loci UGT1A, UGT2B7 and ABCC2.
Pharmacogenomics, vol 9 no 7, July 2008, pp. 869-879.

Girard H*, Lévesque E*, Bellemare J, Journault K, Caillier B, Guillemette C.
Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity.
Pharmacogenet Genomics. 2007 Dec;17(12):1077-89.

M.-O. Benoit-Biancamano, P. Caron, E. Lévesque, R. Delage, F. Couture and C. Guillemette.
Sensitive high-performance liquid chromatography–tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct; 858(1-2): 159-16

E. Lévesque, R. Delage, M-O Benoit-Biancamano, P. Caron, O. Bernard, F. Couture et C. Guillemette.
The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
Clin Pharmacol Ther 2007 Mar;81(3):392-400

E. Lévesque*, H. Girard*, K. Journault, J. Lépine, C. Guillemette.
Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus.
Hepatology. 2007 Jan;45(1):128-38.

E. Lévesque, D. Turgeon, J.-S. Carrier, V. Montminy, M. Beaulieu and A. Bélanger (2001).
Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronsyltransferase.
Biochemistry 40 (13): 3869-81.

E. Lévesque, Hum, D.W., Bélanger, A.
Rôle des UDP-glucuronosyltransférases dans le métabolisme des stéroïdes. (2000)
Médecine/Sciences.

Turgeon, D., J. S. Carrier, E. Lévesque, D.-W. Hum and A. Bélanger (2001).
Relative enzymatic activity, protein stability and tissue distribution of human steroid metabolizing UGT2B subfamily members.
Endocrinology 142 (2): 778-787.

Turgeon, D., J. S. Carrier, E. Lévesque, B. G. Beatty, A. Bélanger and D. W. Hum (2000).
Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4.
J Mol Biol 295: 489-504.

Barbier, O., E. Lévesque, A. Bélanger and Hum D.W. (1999).
UGT2B23, a Novel Uridine Diphosphate-Glucuronosyltransferase Enzyme Expressed in Steroid Target Tissues that Conjugates Androgen and Estrogen Metabolites.
Endocrinology 140(12): 5538-5548.

Dubois, S., M. Beaulieu, E. Lévesque, D. W. Hum and A. Bélanger (1999).
Alteration of human UDP-glucuronosyltransferase UGT2B17 Regio-specificity by a single amino acid substitution.
J. Mol. Biol. 289: 29-39.

E. Lévesque, M. Beaulieu, D. Hum and A. Bélanger (1999).
Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
Pharmacogenetics 9: 207-216.

Tchernof, A., E. Lévesque, M. Beaulieu, P. Couture, J. P. Després, D. W. Hum and A. Bélanger (1999).
Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method.
Clin. Endocrinol. 50: 637-642.

Beaulieu, M., E. Lévesque, O. Barbier, D. Turgeon, G. Bélanger, D. W. Hum and A. Bélanger (1998).
Isolation and characterization of a simian UDP-glucuronosyltransferase (UGT2B18) active on 3-hydroxyandrogens.
J. Mol. Biol. 275: 785-794.

Beaulieu, M., E. Lévesque, D. W. Hum and A. Bélanger (1998).
Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11.
Biochem. Biophys. Res. Commun. 248: 44-50.

E. Lévesque, M. Beaulieu, C. Guillemette, D. W. Hum and A. Bélanger (1998).
Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line.
J. Steroid Biochem Molec. Biol. 64: 43-48.

E. Lévesque, M. Beaulieu, C. Guillemette, D. W. Hum and A. Bélanger (1998).
Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine dipohosphate-glucuronosyltransferase expression and activity in the LNCaP cell line.
Endocrinology 139: 2375-2381.

Bélanger, G., M. Beaulieu, E. Lévesque, D. W. Hum and A. Bélanger (1997).
Expression and Characterization of a Novel UDP-Glucuronosyltransferase UGT2B9, from Cynomolgus Monkey.
DNA Cell Biol. 16: 1195-1205.

Guillemette, C., E. Lévesque M. Beaulieu, D. Turgeon, D. W. Hum and A. Bélanger (1997).
Differential regulation of two steroid glucuronosyltransferases, UGT2B15 and UGT2B17, by androgen and epidermal growth factor.
Endocrinology 138: 2998-3005.

E. Lévesque, M. Beaulieu, M. D. Green, T. R. Tephly, A. Bélanger and D. W. Hum (1997).
Isolation and Characterization of UGT2B15(Y85): A UDP-Glucuronosyltransferase Encoded by a Polymorphic Gene.
Pharmacogenetic 7: 317-325.

Beaulieu, M., E. Lévesque, A. Tchernof, B. G. Beatty, A. Bélanger and D. W. Hum (1997).
Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme.
DNA Cell Biol 16(10): 1143-1154.

E. Lévesque, Beaulieu, M., D. W. Hum and A. Bélanger (1996).
Isolation and characterization of novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids.
J. Biol. Chem. 271: 22855-22862.

Bélanger, G., M. Beaulieu, B. Marcotte, E. Lévesque, C. Guillemette, D. W. Hum and A. Bélanger (1995).
Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line.
Mol. Cell. Endocrinol. 113: 165-173.

Oral and poster communications

M-O Benoit-Biancamano, E. Lévesque, R. Delage, F. Couture et C. Guillemette.
UGT2B7 haplotypes but not MRP2 genetic variations are associated with pharmacokinetic variations of mycophenolate mofetil in healthy subjects.
ASCPT Annual Meeting, Anaheim, California, March 21-24, 2007

E. Lévesque, R. Delage, M-O Benoit Biancamano, F. Couture, et C. Guillemette.
UGT1A8 and UGT1A9 as Molecular Determinants of Mycophenolate Mofetil (MMF) Pharmacokinetics.
48th ASH Annual Meeting, Atlanta, Georgia, December 8-11, 2006

Bélanger, G., E. Lévesque and A. Bélanger (1994).
Présence de l’ARNm de l’UDP glucuronosyltransférase dans des tissus androgéno-dépendents chez le rat.
62e Réunion de l’ACFAS, UQAM, 16-20 mai. Page 137.

Beaulieu, M., E. Lévesque, G. Bélanger, C. Guillemette, D. Hum and A. Bélanger (1995).
Expression of transcripts encoding androgen metabolizing enzymes, UDP-Glucuronosyltransferases, in the androgen dependent human prostatic carcinoma LNCaP cell line.
Annual Meeting of the Canadian Society for Clinical Investigation (CSCI), Montréal, September 13-17. Page B41, Abst. No 254.

Beaulieu, M., E. Lévesque, D. W. Hum and A. Bélanger (1995).
Expression de transcrits encodant des UDP-glucuronosyl transférases spécifiques aux stéroïdes dans des tissus provenant d’une hyperplasie bénigne de prostate et dans la lignée cellulaire LNCaP.
37e Réunion Annuelle du Club de Recherches Cliniques du Québec, Montréal, 28-30 septembre. Page 25, Abst. No 98.

Bélanger, G., B. Marcotte, M. Beaulieu, E.Lévesque, C. Guillemette, D. W. Hum and A. Bélanger (1995).
Presence of UDP-glucuronosyltransferase transcripts mRNA in the human prostate. 12th
International Symposium of the Journal of Steroid Biochemistry and Molecular Biology, Berlin, Germany, May 21-25. Abst. No. 75P.

Lévesque, E., M. Beaulieu, G. Bélanger, D. W. Hum and A. Bélanger (1995).
Détection spécifique de messagers codant des UDP-Glucuronosyltransférases actives sur des stéroïdes dans la prostate humaine et dans la lignée cellulaire LNCaP.
37e Réunion Annuelle du Club de Recherches Cliniques du Québec, Bromont, Québec, Canada, 28-30 septembre. Page 28, Abst. No 115.

Beaulieu, M., E. Lévesque, D. W. Hum and A. Bélanger (1996).
Isolation and characterization of a novel cDNA encoding a human prostatic androgen-specific UDP-glucuronosyltransferase.
2nd International Symposium on Molecular Steroidogenesis, Monterey, CA, USA, June 7-11. Page 27.

Beaulieu, M., E. Lévesque, D. W. Hum and A. Bélanger (1996).
Isolation et caractérisation d’un nouvel ADNc encodant une UDP-glucuronosyltransférase humaine active sur des C19 stéroides.
Club de Recherches Cliniques du Québec. Médecine/Sciences. Page 23, Abst. O-72.

Beaulieu, M., E. Lévesque, D. Turgeon, S. Dubois, D. W. Hum and A. Bélanger (1996).
Obtention et caractérisation d’anticorps polyclonaux dirigés contre des UDP-glucuronosyltransférases humaines actives sur des C19 stéroides.
Club de Recherches Cliniques du Québec. Médecine/Sciences. Page 45, Abst.: P-150.

Bélanger, A., C. Guillemette, E. Lévesque, M. Beaulieu and D. W. Hum (1996).
Glucuronidation of Steroids in Steroid Target Tissues in Humans.
VIIIth International Workshop on Glucuronidation and the UDP-Glucuronosyltransferases, Iowa City, IA, USA, May 19-22. Abst. 053-3.

Bélanger, G., M. Beaulieu, E.Lévesque, D. W. Hum and A. Bélanger (1996).
Molecular cloning and stable expression of a simian UDP-glucuronosyltransferase active on androsterone.
10th International Congress of Endocrinology, San Francisco, CA, USA, June 12-15. Page 877, Abst. P3-489.

Bélanger, G., M. Beaulieu, E. Lévesque, D. W. Hum and A. Bélanger (1996).
Molecular Cloning of UDP-Glucuronosyltransferase Active on Androgens in the Cynomolgus Monkey.
VIIIth International Workshop on Glucuronidation and the UDP-Glucuronosyltransferases, Iowa City, IA, USA, May. P.2.

Hum, D. W., M. Beaulieu, E. Lévesque, G. Bélanger and A. Bélanger (1996).
Characterization of Novel Steroid Specific UGT2B cDNA Clones.
VIIIth International Workshop on Glucuronidation and the UDP-Glucuronosyltransferases, Iowa City, IO, USA, May. Abst.: 053-4.

Lévesque, E., M. Beaulieu, D. Hum, M. D. Green, T. R. Tephly and A. Bélanger (1996).
Cloning and stable expression of two novel human prostate UDP-glucuronosyltransferases with activities on androgens.
10th International Congress of Endocrinology, San Francisco, CA, USA, June 12-15. Page 156, Abst.: P1-83.

Lévesque, E., M. Beaulieu, D. W. Hum and A. Bélanger (1996).
Isolation of novel UGT2B steroid specific cDNA clones.
Le Collège royal des médecins et chirurgiens du Canada, Halifax, NS, Canada, 26 au 29 septembre. Page S23, Abst.: 147.

Lévesque, E., M. Beaulieu, D. W. Hum and A. Bélanger (1996).
Présence de polymorphismes dans la sous-famille UGT2B des UDP-glucuronosyltransférases.
Club de Recherches Cliniques du Québec, Octobre. Page 24, Abst.: O-78.

Barbier, O., D. Turgeon, M. Beaulieu, E. Lévesque, A. Bélanger and D.-W. Hum (1997).
Clonage et caractérisation d’une nouvelle UDP-glucuronosyltransferase (UGT2B18) de singe active sur des androgenes.
Club de Recherche Clinique du Québec, Trois-Rivières, Québec, Canada, 16-17-18 octobre.

Barbier, O., D. Turgeon, M. Beaulieu, E. Lévesque, A. Bélanger and D. W. Hum (1997).
Clonage et caractérisation d’une nouvelle UDP-glucuronosyltransferase (UGT2B18) de singe active sur des androgènes.
39e Réunion Annuelle du Club de Recherches Cliniques du Québec, Québec, Canada, 16, 17 et 18 octobre. Page 23, Abst.: P-007.

Beaulieu, M., E. Lévesque, A. Bélanger and D. W. Hum (1997).
Characterization of the UGT2B17 gene encoding a steroid metabolizing enzyme.
40th Annual Meeting of Canadian Federation of Biological Societies, Québec City, Canada, June 18-21. Abst. No. 022.

Beaulieu, M., E. Lévesque, A. Tchernof, A. Bélanger and D.-W. Hum (1997).
UGT2B17, A steroid metabolizing enzyme: chromosomal localization, genomic structure and gene regulation.
79th Annual Meeting of The Endocrine Society, Minneapolis, MN, USA, June 11-14. Page 569, Abst.: P3-532.

Beaulieu, M., E. Lévesque, A. Tchernof, A. Bélanger and D. W. Hum (1997).
Chromosomal localization, structure and gene regulation of the UGT2B17 gene, a steroid metabolizing enzyme.
CSCI (Le Collège Royal des Médecins et Chirurgiens du Canada), Vancouver, BC, Canada, September 24-28. Abst.: No. 98.

Beaulieu, M., E. Lévesque, A. Tchernof, D. W. Hum and A. Bélanger (1997).
Localisation chromosomique, structure et régulation du gène UGT2B17, une enzyme métabolisant les androgènes.
39e Réunion Annuelle du Club de Recherches Cliniques du Québec, Québec, Canada, 16, 17 et 18 octobre. Page 27, Abst.: P-005.

Bélanger, A., D. W. Hum, C. Guillemette, M. Beaulieu and E. Lévesque (1997).
Characterization and Regulation fo UDP-Glucuronosyltransferases in Steroid Target Tissues.
13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology, Monaco, May 25-28. Abst.: 27.

Guillemette, C., E. Lévesque, M. Beaulieu, D. Turgeon, D. W. Hum and A. Bélanger (1997).
Differential Regulation of Two UDP-Glucuronosyltransferases, UGT2B15 and UGT2B17, in Human Prostate LNCaP Cells.
13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology, Monaco, May 25-28. Abst.: 154.

Lévesque, E., M. Beaulieu, D. W. Hum and A. Bélanger (1997).
Clonage d’une UDP-gucuronosyltransferase humaine active sur les sels bilaires et les catécholestrogènes.
39e Réunion Annuelle du Club de Recherches Cliniques du Québec, Québec, Canada, 16, 17 et 18 octobre. Page 8, Abst.: 0-20.

Lévesque, E., M. Beaulieu, D. W. Hum and A. Bélanger (1997).
Isolation and characterization of a novel cDNA encoding a human polymorphic UDP-glucuronosyltransferase active on bile acids and catecholestrogens.
79th Annual Meeting of the Endocrine Society, Minneapolis, MN, USA. Page 538, Abst. P3-408.

Tchernof, A., M. Beaulieu, E.Lévesque, P. Couture, P. Poncelet, D. W. Hum and A. Bélanger (1997).
Expression d’UGT2B15 et UGT2B17, des enzymes métabolisant les androgenes, dans le tissu adipeux intra-abdominal humain.
39e Réunion Annuelle du Club de Recherches Cliniques du Québec, Québec, Canada, 16-17-18 octobre. Page 34, Abst.: P0-49.

Barbier, O., M. El-Alfy, E. Lévesque, D. W. Hum and A. Bélanger (1998).
Cellular localization of UDP-glucuronosyltransferase sub-family 2B enzymes in human prostate by in situ hybridization and immuno-histochemistry.
9th International Workshop on Glucuronidation and UDP-glucuronosyltransferase, Australia, October 23-27. Abst.: 0-9.

Barbier, O., M. Vallée, E. Lévesque, D. Turgeon, A. Bélanger and D. W. Hum (1998).
Steroids UDP-Glucuronosyltransferase sub-familly 2B (UGT2B) enzymes from cynomolgus monkey.
Int. Symp. Metabolism & Drugs Oxidation 1998, Montpellier, France, July 20-24.

Dubois, S., M. Beaulieu, E.Lévesque, C. Albert, D. W. Hum and A. Bélanger (1998).
Residue 121 is involved in the stereospecificity of the UGT2B17 steroid metabolyzing enzyme.
Int. Symp. Metabolism & Drugs Oxidation 1998, Montpellier, France, 20-24 juillet.

Dubois, S., M. Beaulieu, E. Lévesque, D. W. Hum and A. Bélanger (1998).
Etude de la structure-fonctin d’UGT2B15 et d’UGT2B17 par mutagenese dirigee.
66e Congrès de l’ACFAS, Québec, Canada, 11-15 mai.

Dubois, S., M. Beaulieu, E.Lévesque, D. W. Hum and A. Bélanger (1998).
Structure-function of UGT2B15 and UGT2B17 by site directed mutagenesis.
80th Annual Meeting of the Endocrine Society, New Orléans, LA, USA, June 24-27. Abst.: P1-285.

Dubois, S., E. Lévesque, M. Beaulieu, D. W. Hum and A. Bélanger (1998).
Études sur la régulation et la structure-fonction d’UGT2B15 et d’UGT2B17.
XL Réunion annuelle du Club de Recherches Cliniques du Québec, Québec, Canada, 15-17 octobre. Page 36, Abst.: O-59.

Hum, D. W., A. Bélanger, M. Beaulieu, É. Lévesque and O. Barbier (1998).
The role of UDP glucuronosyltransferase enzymes in steroid metabolism.
Xth International Congress on Hormonal Steroids, Québec, Canada, June 17-21. Abst. no.: S 66.

Lévesque, E., M. Beaulieu, S. Dubois, D.-W. Hum and A. Bélanger (1998).
UGT2B15 and UGT2B17: Régulation and structure-function studies.
9th International Workshop on Glucuronidation and UDP-glucuronosyltransferase, Australia, October 23-27.

Lévesque, E., M. Beaulieu, D. Turgeon, A. Tchernof, D. W. Hum and A. Bélanger (1998).
Peripheral expression of human UGT2B steroid metabolizing enzymes.
9th International Workshop on Glucuronidation and UDP-glucuronosyltransferase, Australia, October 23-27. Abst.: 0-10.

Lévesque, E., M. Beaulieu, M. Vallée and A. Bélanger (1998).
UGT2B4(E458): A UDP-Glucuronosyltransferase encoded by a polymorphic gene with differential substrate specificity.
Imp. Simp. Metabolism & Drugs Oxidation 1998, Montpellier, France, July 20-24.

Lévesque, E., S. Dubois, M. Beaulieu, D. W. Hum and A. Bélanger (1998).
Repression of UGT2B17 gene expression is mediated by AP-1.
80th Annual Meeting of the Endocrine Society, New Orléans, LA, USA, June 24-27. P3-641.

Lévesque, E., S. Dubois, M. Beaulieu, D. W. Hum and A. Bélanger (1998).
La répression de l’expression du gène UGT2B17 est médiée par AP-1.
66e Congrès de l’ACFAS, Québec, Canada, 11-15 mai.

Turgeon, D., O. Barbier, M. Beaulieu, E. Lévesque, D. W. Hum and A. Bélanger (1998).
Clonage et caractérisation d’une nouvelle UDP-glucuronsyltransférase (UGT2B18) de singe active sur les 3-hydroxyandrogènes.
66e Congrès de l’ACFAS, Université Laval, Québec, Canada, 11-15 mai.

Carrier, J. S., D. Turgeon, E. Lévesque, O. Barbier, D. W. Hum and A. Bélanger (1999).
Caractérisation du locus humain 4q13-4q21.1: Identification de nouveaux gènes humains, UGT2B24P, UGT2B25P and UGT2B26P.
41e Réunion Annuelle du Club de Recherches Cliniques du Canada, Québec, Canada, 14-16 octobre. Abst.: O-41.

Carrier, J. S., D. Turgeon, E. Lévesque, O. Barbier, D. W. Hum and A. Bélanger (1999).
Characterization of the 4q13 human UGT locus; identification of novel human UGT genes, UGT2B24P and UGT2B5P.
CDA/CSEM Professional, Conference and Annual Meetings, Ottawa, Ontario, Canada, 13-16 octobre. Abst.: 137.

Girard, C., O. Barbier, M. El Alfy, C. Albert, E. Lévesque, D. Turgeon, A. Bélanger and D. W. Hum (1999).
Le Singe Cynomolgus: Un Modèle pour l’Étude du Métabolisme Extra-Hepatique des Hormones Steroïdiennes.
41e Réunion Annuelle du Club de Recherches Cliniques du Québec, October. Page 13, Abst.: 0-40.

Lévesque, E., S. Dubois, D. W. Hum and A. Bélanger (1999).
Regulation of the UGT2B17 Gene Promoter Expressino in LNCaP Cells.
81st Annual Meeting of the Endocrine Society, San Diego, CA, USA, June 1999.

Montminy, V., E. Lévesque, D. Turgeon, J. S. Carrier, M. Beaulieu, B. Lavallée, D. W. Hum and A. Bélanger (2000).
Isolation and characterization of a cDNA encoding a novel UDP-glucuronosyltransferase, UGT2B28.
The Endocrine Society’s 82nd Annual Meeting, Toronto, Ontario, Canada, June 21-24. Page 372, Abst.:1553.

Turgeon, D., O. Barbier, E. Lévesque, J. S. Carrier, D. W. Hum and A. Bélanger (1999).
Expression of UGT2B enzymes in mammary gland and breast tumor cell lines. La recherche sur le cancer du sein: Raisons d’espérer.
Conférence scientifique nationale, Toronto, Ontario, Canada, June 17-19.

Turgeon, D., O. Barbier, E. Lévesque, J. S. Carrier, D. W. Hum and A. Bélanger (1999).
Expression of UGT2B enzymes in mammary gland and breast tumor cell lines.
CDA/CSEM Professional, Conference and Annual Meetings, Ottawa, Ontario, Canada, October 13-16. Abst.: 138.

Turgeon, D., O. Barbier, E. Lévesque, J. S. Carrier, D. W. Hum and A. Bélanger (1999).
Expression of UGT2B enzymes in mammary gland and breast tumor cell lines.
Breast cancer research: Reasons for Hope, Toronto, Ontario, Canada, 17-19 juin.

Turgeon, D., J. S. Carrier, E. Lévesque, D. W. Hum and A. Bélanger (1999).
Charactéristiques Enzymatiques des UGT2B; Distribution Tissulaire et Activité Relative.
41e Réunion annuelle du Club de Recherches Cliniques du Québec, Québec, Canada, Octobre. Page 14, Abst.:44.

Turgeon, D., E. Lévesque, J.-C. Carrier, O. Barbier, D. W. Hum and A. Bélanger (1999).
Identification of Novel Human UGT Genes, UGT2B24P and UGT2B25P and UGT2B25P on Chromosome 4q13.
81st Annual Meeting of the Endocrine Society, San Diego, CA, USA, June.

Turgeon, D., E. Lévesque, J. S. Carrier, O. Barbier, D. W. Hum and A. Bélanger (1999).
Characterization of the 4q13 human UGT locus; identification of novel human UGT genes, UGT2B24P and UGT2B25P.
81st Annual Meeting of the Endocrine Society, San Diego, CA, USA, June 12-15. Page 345, Abst.: P2-308.

Turgeon, D., J. S. Carrier, E. Lévesque, D. W. Hum and A. Bélanger (2000).
Relative enzymatic activity protein stability and tissue distribution of human steroid metabolizing UGT2B subfamily members.
The Endocrine Society’s 82nd Annual Meeting, Toronto, Ontario, Canada, June 21-24, 2000. Abst.: 1545.

Book Chapters

Dean W Hum, Alain Bélanger, Éric Lévesque, Olivier Barbier, Martin Beaulieu, Caroline Albert, Michel Vallee, Chantal Guillemette, Andre Tchernof, David Turgeon and Stephanie Dubois.
Characterization of UDP-glucuronosyltransferases active on steroid hormones.
Journal of Steroid Biochemistry and Molecular Biology, 69:413-423, 1999

Alain Bélanger, Dean W Hum, Martin Beaulieu, Éric Lévesque, Chantal Guillemette, Andre Tchernof, Guy Bélanger, David Turgeon and Stephanie Dubois.
Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
Journal of Steroid Biochemistry and Molecular Biology, 65:301-10, 1998